Products/Services Used | Details | Operation |
---|---|---|
Catalog Antibody> | Samples were incubated overnight at 4°C with primary antibodies against 4EBP1 (1:500, ab37225, Abcam), p-4EBP1 (1:500, #2855, Cell Signaling Technology, Danvers, MA), S6 (1:500, #2317, Cell Signaling Technology), p-S6 (1:1,000, #4858, Cell Signaling Technology), vimentin (1:250, ab92547, Abcam, Cambridge, MA), p-STAT3 (Tyr705, 1:100, #9131, Cell Signaling Technology), STAT3 (1:1,600, #9139, Cell Signaling Technology), bIII-tubulin (1:500, PRB-435B, Covance, Dedham, MA), Tau (1:500, A00393, GenScript, Piscataway, NJ), ERK (1:500, #4696, Cell Signaling Technology), p-ERK (1:500, #4370, Cell Signaling Technology), or ATF4 (1:1,000, ab50546, Abcam). | Get A Quote |
Neurons frequently encounter neurodegenerative signals first in their periphery. For example, exposure of axons to oligomeric Aβ is sufficient to induce changes in the neuronal cell body that ultimately lead to degeneration. Currently, it is unclear how the information about the neurodegenerative insult is transmitted to the soma. Here, we find that the translation of pre-localized but normally silenced sentinel mRNAs in axons is induced within minutes of Aβ addition in a Ca-dependent manner. This immediate protein synthesis following Aβ exposure generates a retrograde signaling complex including vimentin. Inhibition of the immediate protein synthesis, knock-down of axonal vimentin synthesis, or in... More